Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 USD | 0.00% | -37.50% | -63.64% |
02-22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
420K | - | - | - | - | - | |
62.59B | - | |||||
41.18B | ||||||
40.29B | ||||||
27.9B | ||||||
26.21B |
- Stock Market
- Equities
- BXRXQ Stock
- Charts Baudax Bio, Inc.
- Sector Chart